Ethnicity, aggression and serum creatine kinase in hospitalized male forensic patients

Ethnicity and Disease

Volumn 7, Issue 3, 1997, Pages 259-270

  Spitz, Reuben T ^a   Hillbrand, Marc ^b,c   Foster, Hilliard G ^c   Svetina, Christine J ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Young Adult Services   (United States)

Author keywords

Aggression; Creatine kinase; Ethnicity; Stress

Indexed keywords

CREATINE KINASE;

ADOLESCENT; ADULT; AGED; AGGRESSION; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; CAUCASIAN; COMPARATIVE STUDY; ENZYMOLOGY; ETHNOLOGY; FORENSIC PSYCHIATRY; GENETICS; HOSPITALIZATION; HUMAN; MALE; MENTAL DISEASE; MULTIVARIATE ANALYSIS; NEGRO; REPRODUCIBILITY; RETROSPECTIVE STUDY; STATISTICS; UNITED STATES; VIOLENCE;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGGRESSION; ANALYSIS OF VARIANCE; CONNECTICUT; CREATINE KINASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FORENSIC PSYCHIATRY; HOSPITALIZATION; HUMANS; MALE; MENTAL DISORDERS; MULTIVARIATE ANALYSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; VIOLENCE;

EID: 0031218767     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Bengzon A, Hippius H, Kanig, K. Some changes in the serum during treatment with psychotropic drugs. J Nerv Ment Dis. 1966;143:369-376.
2. Meltzer HY. Creatine kinase and aldolase in serum: abnormality common to acute psychosis. Science. 1968;159:1368-1370.
3. Schiavone DJ, Kaldor J. Creatine phosphokinase levels and cerebral disease. Med J Australia. 1965; 52:790-792.
4. Cohen DJ, Johnson W, Caparulo J. Creatine phosphokinase levels in children with severe developmental disturbance. Arch Gen Psychiatry. 1976; 33:683-686.
5. Crayton JW, Meltzer HY. Serum creatine phosphokinase activity in psychiatrically hospitalized children. Arch Gen Psychiatry. 1976;33:679-681.
6. Cunningham LA, Rich CL, Woodruff RA, Olney, JA. Creatine phosphokinase and psychiatric illness. Brit J Psychiatry. 1974;124:87-91.
7. Foster FG, Kupfer DJ. Psychomotor activity and serum creatine phosphokinase activity. Arch Gen Psychiatry. 1973;29:752-758.
8. Guterman A. Manifest psychopathology and serum creatine phosphokinase: a correlational study. Dis Nerv Sys. 1973;34:49-53.
9. Meltzer HY. Muscle enzyme release in the acute psychoses. Arch Gen Psychiatry. 1969;21:102-122.
10. Meltzer HY. Factors affecting serum creatine phosphokinase levels in the general population: The role of race, activity and age. Clin Clim Acta. 1971;33:165-172.
11. Meltzer HY. Creatine phosphokinase activity and clinical symptomatology. Arch Gen Psychiatry. 1973;29:589-593.
12. Meltzer HY. Serum creatine phosphokinase in schizophrenia. Am J Psychiatry. 1976;133:192-197.
13. Meltzer HY, Holy PA. Black-white differences in serum creatine phosphokinase(CPK) activity. Clin Chim Acta. 1974;54:215-224.
14. Meltzer HY, Moline R. Plasma enzymatic activity after exercise. Arch Gen Psychiatry. 1970;22:390-397.
15. Meltzer HY, Moline R. Muscle abnormalities in the acute psychoses. Arch Gen Psychiatry. 1970; 23:481-491.
16. Meltzer HY, Ross-Stanton J, Schlessinger S. Mean serum creatine kinase activity in patients with functional psychoses. Arch Gen Psychiatry. 1980; 37:650-655.
17. Soni SD. Serum creatine phosphokinase in acute psychosis. Brit J Psychiatry. 1976;128:181-183.
18. Swartz CM, Breen KA. Multiple muscle enzyme release with psychiatric illness. J Nerv Ment Dis. 1990;178:755-759.
19. Taylor JR, Abichandani L. Creatine phosphokinase elevations and psychiatric symptomatology. Biol Psychiatry. 1980;15:865-870.
20. Spratto GS, Woods AL. NDR-92: Nurse's Drug Reference. New York, NY: Delmar; 1992.
21. Black HR, Quallich H, Garleck CB. Racial differences in serum creatine kinase levels. Am J Med. 1986;81:479-487.
22. Thomas CL. Taber's Cyclopedic Medical Dictionary, 17th ed. Philapdelphia, Pa: F.A. Davis; 1993.
23. Egan MF, Dargham AA, Kirch DG, Wyatt, RJ. Serum creatine phosphokinase elevations in patients with tardive dyskinesia. Brit J Psychiatry. 1993;162:551-553.
24. Engel WK, Meltzer HY. Histochemical abnormalities of skeletal muscle in patients with acute psychoses. Science. 1970;168:273-275.
25. Meltzer HY, Crayton JW. Subterminal motor nerve abnormalities in psychotic patients. Nature. 1974; 249:373-375.
26. Gledhill RF, vanNiekerk MM, vanderMerwe CA. Racial differences in serum creatine kinase levels. Am J Med. 1987;83:365.
27. Miller WG, Gruemer HD, Chinchill VM. Upper reference limit for creatine kinase. Clin Chem. 1985;31:158.
28. Wong ET, Cobb C, Umehara MK, Wolff, MS, Haywood, LJ, Greenberg, T, Shaw, ST. Heterogeneity of serum creatine kinase activity among racial and gender groups of the population. Am J Clin Pathol. 1983;79:582-586.
29. Cook JC, Wong E, Haywood LJ. Creatine kinase: race-gender differences in patients hospitalized for suspected myocardial infarction. J Nat Med Assoc. 1990;82:249-254.
30. Meltzer HY. Neuromuscular abnormalities in the major mental illnesses. I. Serum enzyme studies. In: Freedman DX, ed. Biology of the Major Psychoses. New York, NY:Raven Press; 1975:165-188.
31. Isaacs JS, Yesavage JA. Serum creatine phosphokinase levels and assaultive behaviour of psychotic patients. Psychol Med. 1984;14:229-231.
32. Hillbrand M, Spitz RT, Foster HG, Krystal, LH, Young, JL. Creatine kinase elevations and aggressive behavior in hospitalized forensic patients. Psychiatric Q. In press.
33. Foster HG, Spitz RT. Biochemistry and aggression: a psychohematological model. In: Hillbrand M, Pallone NJ, eds. The Psychobiology of Aggression. Binghamton,NY: Haworth Press; 1994: 115-125.
34. Hillbrand M, Krystal JH, Sharpe K, Foster HG. Clinical predictors of self-mutiliation in hospitalized forensic patients. J Nerv Mem Dis. 1995;182: 9-13.
35. Hillbrand M, Spitz RT, Foster HG. Serum cholesterol and aggression in hospitalized forensic patients. J Beh Med. 1995;18: 33-43.
36. Hillbrand M, Young JL, Krystal JH. Recurrent self-injurious behavior in forensic behavior. Psychiatric Q. 1996; 67:33-45.
37. Spitz RT, Foster HG, Hillbrand M. Hematological changes and severity of aggression in black and white forensic patients. Psychol Rep. 1993;73: 1105-1106.
38. Spitz RT, Hillbrand M, Foster HG. Uric acid levels and severity of aggression. Psychol Rep. 1995;76: 130.
39. 45 CFR, Part 46. Protection of human subjects. 1983; par. 101:5.
40. Silver JM, Yudofsky SC. Documentation of aggression in the assessment of the violent patient. Psychiatr Ann. 1987;17:367-370.
41. Silver JM, Yudofsky SC. Aggressive behavior in patients with neuropsychiatric disorders. Psychiatr Ann. 1987;17:375-384.
42. Yudofsky SC, Silver JM, Jackson W, Endicott J, Williams D. The Overt Aggression Scale for the objective rating of verbal and physical aggression. Am J Psychiatry. 1986;143:35-39.
43. Hillbrand M. Self-directed and other-directed aggressive behavior in a forensic sample. Suicide Life Threat Behav. 1992;22:333-340.
44. Hillbrand M. Aggression against self and aggression against others in violent psychiatric patients. J Consult Clin Psychol. 1995;63:668-671.
45. Vale S, Espejel MA, Calcaneo F. Creatine phosphokinase: increased activity of the spinal fluid in psychotic patients. Arch Neurol. 1974;30:103-104.
46. Taylor JR. Massive creatine phosphokinase elevation with acute psychosis. Biol Psychiatry. 1977;12:589-592.
47. Johnson SB, Alvarez WA, Freinhar JP. A case of massive rhabdomyolysis following molindine administration. J Clin Psychiatry. 1986;47:607-608.
48. Asterita MF. The Physiology of Stress. New York, NY: Human Sciences Press; 1985.
49. Selye H. The Stress of Life. New York, NY: McGraw-Hill; 1978.
50. Van Vliet PD, Burchell HB, Titus JL. Focal myocarditis associated with pheochromocytoma. N Eng J Med. 1966;274:1102-1108.
51. Maguire JF, Geha RS, Umetsu DT. Myocardial specific creatine phosphokinase elevation in children with asthma treated with intravenous iosproterenol. J Allerg Clin Immunol. 1986;78:631-636.
52. Bhatagnar D, Carey P, Pollard A. Focal myositis and elevated creatine kinase level in a patient with pheochromocytoma. Postgrad Med J. 1986;62: 197-198.
53. Gurrera RJ, Romero JA. Enzyme elevations in the neuroteptic malignant syndrome. Biol Psychiatry. 1993;34:634-640.
54. Bloom S. Catecholamine cardiomyopathy. N Eng J Med. 1987;317:900.
55. Gurrera RJ, Romero JA. Sympathoadrenomedullary activity in the neuroleptic malignant syndrome. Biol Psychiatry. 1992;32:334-343.
56. Calhoun DA, Mutinga ML, Collins AS, Wyss JM, Oparil S. Normotensive blacks have heightened sympathetic response to cold pressor test. Hypertension. 1993;22:801-805.
57. Wehle M, Harris P, Hilton FK. Influence of aggression on erythropoesis: the hypersympathetic syndrome. Physiol Beh. 1978;21:711-716.
58. Peters DAV. Prenatal stress: effects on brain biogeniv amine and plasma corticosteroid levels. Pharm Biochem Beh. 1982; 17:721-725.
59. Antonovsky A. Social class, life expectancy and overall mortality. Millbank Mem Fund Q. 1967; 45:31-73.
60. Palinkas LA, Colcord CL. Health risks among enlisted males in the US Navy: race and ethnicity as correlates of disease incidence. Soc Sci Med. 1985; 20:1129-1141.
61. Curtin PD. The slavery hypothesis for hypertension among African Americans: the historical evidence. Am J Public Health. 1992;82:1681-1686.
62. Chrysant SG, Frolich ED, Adamopoulos PN, Stein PD, Whitcomb WW, Allen EW, Neller G. Pathophysiologic significance of "stress" or relative polycythemia in essential hypertension. Am J Cardiol. 1976;37:1069-1072.
63. Falkner B, Kushner H. Effect of chronic sodium loading on cardiovascular response in young blacks and whites. Hypertension. 1990;15:36-43.
64. Anderson NB, Lane JD, Taguchi F, Williams RB. Patterns of cardiovascular responses to stress as a function of race and parental hypertension in men. Health Psychol. 1989;8:525-540.
65. Calhoun DA. Hypertension in blacks: socioeconomic stress and sympathetic nervous system activity. Am J Med Sci. 1992;304:306-311.
66. Folkow B. Physiological aspects of primary hypertension. Physiol Rev. 1982;62:347-504.
67. Fabrega H. Neurobiology, culture, and behavior disturbances: an integrative review. J Nerv Ment Dis. 1979;167:8.
68. Escobar JL, Mendoza R, Stimmel G. The DST in a large outpatient clinic: its diagnostic and predictive significance. Psychopharm Bull. 1984;20:89-92.
69. Hammond WR, Yung B. Psychology's role in the public health response to assaultive violence among young African-American men. Am Psychol. 1993;48:142-154.
70. Durel LA, Carver CS, Spitzer SB. Associations of blood pressure with self-report measures of anger and hostility among black and white men and women. Health Psychol. 1989;8:557-575.
71. Lassiter RF. Child-rearing in black families: childabusing discipline? In: Hampton RL, ed. Violence in the Black Family: Correlates and Consequences. Lexington, MA: Lexington Books; 1987: 39-53.
72. Alvy KT. Black Parenting: Strategies for Training. New York, NY: Irvington; 1987.
73. Graziano AM, Namaste KA. Parental use of physical force in child discipline: a survey of 679 college students. J Interper Viol. 1990;5:449-463.